Register Login

Sera Prognostics Inc (SERA)

(99% Neutral) Sera Prognostics, Inc. (SERA) Announces Enrollment Update for contained Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Jan. 8, 2026, 10:23 p.m.

    📋 Sera Prognostics, Inc. (SERA) - Clinical Trial Update

    Filing Date: 2026-01-08

    Accepted: 2026-01-08 17:20:58

    Event Type: Clinical Trial Update

    Event Details:

    Sera Prognostics Inc (SERA) Announces Clinical Trial Update Sera Prognostics Inc (SERA) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: contained, disclosed

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Sera Prognostics Inc
    • CIK: 0001534969
    • Ticker Symbol: SERA
    • Period End Date: 2026-01-08
    • Document Type: 8-K

Search

News categories